BRN.AX is trading 6.7% up now at $0.16 after announcing the commercial availability and initial production shipments of its AKD1500 neuromorphic AI chips.

  • The move marks a clear transition from R&D to full-scale commercialization, with production quantities already shipping to customers across defense and wearable edge AI applications.
  • Developed in partnership with GlobalFoundries, the milestone has fueled renewed investor optimism regarding BrainChip’s commercialization roadmap and future product revenue.